Anti-Inflammatory Therapeutics


Tejal

Uploaded on Jan 29, 2024

Category Lifestyle

Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain.

Category Lifestyle

Comments

                     

Anti-Inflammatory Therapeutics

Anti-Inflammatory Therapeutics Market Size, Share, Competitive Landscape and Trend Analysis Report by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, and Biologics), Indication Type (Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Anti- inflammatory Bowel Disease (IBD), and Other Anti-inflammatory Diseases): Global Opportunity Analysis and Industry Forecast, 2021-2028 Anti-Inflammatory Therapeutics Market by Component Global The global anti-inflammatory therapeutics market size was $98,026 million in 2020 and is projected to reach $125,552 million by 2028, registering a CAGR of 4.0% from 2021 to 2028. Anti-inflammatory therapeutic is a drug that eases acute & chronic pain as well as inflammation (redness, swelling, and pain). Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. Browse Complete Report Anti-Inflammatory Therapeutics Market by Component Global The scope of global anti-inflammatory therapeutics market is segmented into indication, drug class, and region. Depending on indication, the market is categorized into arthritis, respiratory diseases, multiple sclerosis, psoriasis, anti-inflammatory bowel disease (IBD), and other anti-inflammatory diseases. By drug class, it is segregated into nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics.  REQUEST SAMPLE Anti-Inflammatory Therapeutics Market by Component Global The scope of global anti-inflammatory therapeutics market is segmented into indication, drug class, and region. Depending on indication, the market is categorized into arthritis, respiratory diseases, multiple sclerosis, psoriasis, anti- inflammatory bowel disease (IBD), and other anti-inflammatory diseases. By drug class, it is segregated into nonsteroidal anti- inflammatory drugs (NSAIDs), corticosteroids, and biologics.  Anti-Inflammatory Therapeutics Market by Component Global Key Benefits •This report entails a detailed quantitative analysis along with the current global anti-inflammatory therapeutics market trends from 2020 to 2028 to identify the prevailing opportunities along with the strategic assessment. •The anti-inflammatory therapeutic market forecast is studied from 2021 to 2028. •The anti-inflammatory therapeutics market size and estimations are based on a comprehensive analysis of key developments in the ultrasound device industry. •A qualitative analysis based on innovative products facilitates strategic business planning. •The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the anti-inflammatory therapeutics market. Connect Analyst Anti-Inflammatory Therapeutics Market by Component Global Anti-Inflammatory Therapeutics Market Key Segments: By Region •North America • U.S. • Canada • Mexico •Europe • UK • Germany • France • Russia • Rest of Europe •Asia-Pacific • China • Japan • India • Australia • Rest of Asia-Pacific •LAMEA • Latin America • Middle East • Africa Anti-Inflammatory Therapeutics Market by Component Global Segment Overview The global anti-inflammatory therapeutics market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period.  Anti-Inflammatory Therapeutics Market by Component Global Key players profiled in the report iAnsctrlauZdenee ca PLC., PFIZER INC., Amgen Inc, Novartis AG, Merck & Co., Inc., Johnson & Johnson, Eli Lily and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc Anti-Inflammatory Therapeutics Market by Component Global Contact: Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503- 446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1⟨855⟩550-5975 help@alliedmarketresearch. com Web: https://www.alliedmarketre search.com Purchase enquiry ttps://www.alliedmarketresearch.com/purchase-enquiry/2095